Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Clinical trial NCT00795171 · UNKNOWN

Trial details

NCT number: NCT00795171
Sponsor: Medical University of Vienna
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer

Start date: 2008-11-01
Primary completion: 2011-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.